证券记录 · 已归档季度
STAA
STAAR Surgical Company · Healthcare · Medical - Instruments & Supplies
10被追踪持有人
-2Δ持有人
5.93M持有股份
$144.12M报告持仓市值
+1新建仓位
−3清仓
动量输入（同类管理人）：
持有人广度 -16.7% ·
股份流向 -21.6% ·
净新建仓位 -20.0%
— 公式
广泛派发 — 持股数量下降且持有人减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q4 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 75 | +6 | 22.78M | $653.08M | +13 | −6 |
| Q1 2026 | 71 | -2 | 21.75M | $407.04M | +10 | −12 |
| Q4 2025 | 73 | +2 | 25.59M | $590.84M | +2 | — |
| Q3 2025 | 16 | +2 | 16.83M | $452.11M | +3 | −1 |
| Q2 2025 | 11 | 0 | 16.25M | $272.61M | — | — |
| Q1 2025 | 8 | -2 | 3.84M | $67.78M | +1 | −3 |
| Q4 2024 | 10 | -2 | 5.93M | $144.12M | +1 | −3 |
| Q3 2024 | 11 | +1 | 5.51M | $204.79M | +2 | −1 |
| Q2 2024 | 10 | — | 5.61M | $267.04M | — | — |
持有人 · Q4 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (被动) | 2.05M | — | $49.86M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (被动) | 1.17M | 0.0% | $28.54M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 3 | Geode Capital Management ✦ (被动) | 1.17M | 0.0% | $28.54M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | Baillie Gifford ✦ | 1.15M | -21.0% | $28.03M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 5 | Baillie Gifford ✦ | 1.15M | -21.0% | $28.03M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 6 | Baillie Gifford ✦ | 1.15M | -21.0% | $28.03M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 7 | Baillie Gifford ✦ | 1.15M | -21.0% | $28.03M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 8 | Millennium Management ✦ | 759.14K | -9.9% | $18.44M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 9 | Citadel Advisors ✦ | 321.52K | -65.6% | $7.81M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 321.52K | -65.6% | $7.81M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 11 | Marshall Wace ✦ | 152.55K | -55.7% | $3.71M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 12 | Marshall Wace ✦ | 152.55K | -55.7% | $3.71M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 13 | Marshall Wace ✦ | 152.55K | -55.7% | $3.71M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 14 | Marshall Wace ✦ | 152.55K | -55.7% | $3.71M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 15 | Renaissance Technologies ✦ | 138.10K | -54.6% | $3.35M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 94.88K | +4.6% | $2.30M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 94.88K | +4.6% | $2.30M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | D. E. Shaw & Co. ✦ | 50.25K | 新增 | $1.22M | 0.0% | New | 1 | SEC ↗ |
| 19 | T. Rowe Price ✦ | 35.61K | +9.4% | $866,000 | 0.0% | ▲ Add | 3 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| D. E. Shaw & Co. | $1.22M | 0.0% |
已清仓
| Norges Bank | $10.12M | 曾为 0.0% |
| Two Sigma Investments | $1.39M | 曾为 0.0% |
| Bridgewater Associates | $716,289 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 186 持有人, 53.87M 股份, $998.22M 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
Aug 14
SC 13G/A — Madison Avenue Partners, LP
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q4 2024 ·
方法论 ·
通过API获取此数据